Wendy K. Steagall

2.0k total citations
34 papers, 896 citations indexed

About

Wendy K. Steagall is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Wendy K. Steagall has authored 34 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Physiology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Rheumatology. Recurrent topics in Wendy K. Steagall's work include Tuberous Sclerosis Complex Research (24 papers), Eosinophilic Disorders and Syndromes (10 papers) and Vascular Tumors and Angiosarcomas (6 papers). Wendy K. Steagall is often cited by papers focused on Tuberous Sclerosis Complex Research (24 papers), Eosinophilic Disorders and Syndromes (10 papers) and Vascular Tumors and Angiosarcomas (6 papers). Wendy K. Steagall collaborates with scholars based in United States, Italy and Netherlands. Wendy K. Steagall's co-authors include Joel Moss, Angelo M. Taveira‐DaSilva, Gustavo Pacheco–Rodriguez, Susan Payne, Frederick J. Fuller, Stephanie T. Perry, Thomas J. Kelley, Mario Stylianou, Thomas N. Darling and Mitchell L. Drumm and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Wendy K. Steagall

33 papers receiving 885 citations

Peers

Wendy K. Steagall
Anna Sirotina United States
Adrienne Verhoef United Kingdom
Franz Puttur United Kingdom
Dario Magaletti United States
Wendy K. Steagall
Citations per year, relative to Wendy K. Steagall Wendy K. Steagall (= 1×) peers Katja C. Beier

Countries citing papers authored by Wendy K. Steagall

Since Specialization
Citations

This map shows the geographic impact of Wendy K. Steagall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy K. Steagall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy K. Steagall more than expected).

Fields of papers citing papers by Wendy K. Steagall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy K. Steagall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy K. Steagall. The network helps show where Wendy K. Steagall may publish in the future.

Co-authorship network of co-authors of Wendy K. Steagall

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy K. Steagall. A scholar is included among the top collaborators of Wendy K. Steagall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy K. Steagall. Wendy K. Steagall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steagall, Wendy K., Mario Stylianou, Gustavo Pacheco–Rodriguez, Zu Xi Yu, & Joel Moss. (2023). Unexpected sirolimus-stimulated airway hyperreactivity in lymphangioleiomyomatosis. ERJ Open Research. 9(4). 305–2023. 1 indexed citations
2.
Yao, Jianhua, Wendy K. Steagall, Nilo A. Avila, et al.. (2019). Use of CT Imaging to Quantify Progression and Response to Treatment in Lymphangioleiomyomatosis. CHEST Journal. 155(5). 962–971. 18 indexed citations
3.
Steagall, Wendy K., Mario Stylianou, Gustavo Pacheco–Rodriguez, & Joel Moss. (2019). Angiotensin-converting enzyme inhibitors may affect pulmonary function in lymphangioleiomyomatosis. JCI Insight. 4(5). 5 indexed citations
4.
Steagall, Wendy K., Gustavo Pacheco–Rodriguez, Thomas N. Darling, et al.. (2018). The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models. American Journal of Respiratory Cell and Molecular Biology. 58(6). 678–683. 12 indexed citations
5.
Cui, Ye, Wendy K. Steagall, Gustavo Pacheco–Rodriguez, et al.. (2017). Aberrant SYK Kinase Signaling Is Essential for Tumorigenesis Induced by TSC2 Inactivation. Cancer Research. 77(6). 1492–1502. 15 indexed citations
6.
Klover, Peter, Rajesh L. Thangapazham, Jiro Kato, et al.. (2017). Tsc2 disruption in mesenchymal progenitors results in tumors with vascular anomalies overexpressing Lgals3. eLife. 6. 12 indexed citations
7.
Glasgow, Connie G., Gustavo Pacheco–Rodriguez, Wendy K. Steagall, et al.. (2017). CA-125 in Disease Progression and Treatment of Lymphangioleiomyomatosis. CHEST Journal. 153(2). 339–348. 24 indexed citations
8.
Valencia, Julio C., Wendy K. Steagall, Yi Zhang, et al.. (2014). Antibody αPEP13h Reacts With Lymphangioleiomyomatosis Cells in Lung Nodules. CHEST Journal. 147(3). 771–777. 4 indexed citations
9.
Steagall, Wendy K., Gustavo Pacheco–Rodriguez, Connie G. Glasgow, et al.. (2013). Osteoprotegerin Contributes to the Metastatic Potential of Cells with a Dysfunctional TSC2 Tumor-Suppressor Gene. American Journal Of Pathology. 183(3). 938–950. 7 indexed citations
10.
Cai, Xiong, Gustavo Pacheco–Rodriguez, Qingyuan Fan, et al.. (2010). Phenotypic Characterization of Disseminated Cells with TSC2 Loss of Heterozygosity in Patients with Lymphangioleiomyomatosis. American Journal of Respiratory and Critical Care Medicine. 182(11). 1410–1418. 46 indexed citations
11.
Terasaki, Yasuhiro, Kinnosuke Yahiro, Gustavo Pacheco–Rodriguez, et al.. (2010). Effects of Prolactin on TSC2 -Null Eker Rat Cells and in Pulmonary Lymphangioleiomyomatosis. American Journal of Respiratory and Critical Care Medicine. 182(4). 531–539. 13 indexed citations
12.
Pacheco–Rodriguez, Gustavo, Fumiyuki Kumaki, Wendy K. Steagall, et al.. (2009). Chemokine-Enhanced Chemotaxis of Lymphangioleiomyomatosis Cells with Mutations in the Tumor Suppressor TSC2 Gene. The Journal of Immunology. 182(3). 1270–1277. 45 indexed citations
13.
Glasgow, Connie G., Angelo M. Taveira‐DaSilva, Gustavo Pacheco–Rodriguez, et al.. (2009). Involvement of Lymphatics in Lymphangioleiomyomatosis. Lymphatic Research and Biology. 7(4). 221–228. 14 indexed citations
14.
Taveira‐DaSilva, Angelo M., Wendy K. Steagall, & Joel Moss. (2009). Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going. F1000 Medicine Reports. 1. 4 indexed citations
15.
Steagall, Wendy K., Connie G. Glasgow, Olanda Hathaway, et al.. (2007). Genetic and morphologic determinants of pneumothorax in lymphangioleiomyomatosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 293(3). L800–L808. 43 indexed citations
16.
Steagall, Wendy K., Connie G. Glasgow, Mary Ehrmantraut, et al.. (2007). Beta-2-adrenergic receptor polymorphisms in cystic fibrosis. Pharmacogenetics and Genomics. 17(6). 425–430. 11 indexed citations
17.
Paone, Gregorino, Linda A. Stevens, Rodney L. Levine, et al.. (2006). ADP-ribosyltransferase-specific Modification of Human Neutrophil Peptide-1. Journal of Biological Chemistry. 281(25). 17054–17060. 48 indexed citations
18.
Steagall, Wendy K., Jingping Lin, & Joel Moss. (2006). The C/A(−18) polymorphism in the surfactant protein B gene influences transcription and protein levels of surfactant protein B. American Journal of Physiology-Lung Cellular and Molecular Physiology. 292(2). L448–L453. 14 indexed citations
19.
Steagall, Wendy K. & Mitchell L. Drumm. (1999). Stimulation of cystic fibrosis transmembrane conductance regulator–dependent short-circuit currents across ΔF508 murine intestines☆, ☆☆. Gastroenterology. 116(6). 1379–1388. 19 indexed citations
20.
Steagall, Wendy K., Michael D. Robek, Stephanie T. Perry, Frederick J. Fuller, & Susan Payne. (1995). Incorporation of Uracil into Viral DNA Correlates with Reduced Replication of EIAV in Macrophages. Virology. 210(2). 302–313. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026